Insider trade

Officer sold ~$118K of AHCO shares in the open market

Traded Jul 1, 2026 · Filed Jul 6, 2026

Why it stands out

AdaptHealth's Chief Commercial Officer sold $118K of AdaptHealth shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Officer$100K–$500KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$117,711

Shares × reported transaction price

Timing vs results

57 days after results of May 5, 2026, 34 days before results of Aug 4, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+0.4%	+0.6%	−0.2%
30 days	−40.4%	+2.8%	−43.2%
90 days	−43.5%	+3.6%	−47.1%

Past results only. Not a forecast.

The sale reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2026.

3mo ago

Compensation award — excluded from discretionary-purchase analysis.

3mo ago

Compensation award — excluded from discretionary-purchase analysis.

3mo ago

Compensation award — excluded from discretionary-purchase analysis.